In debate over obesity medications, FDA shifts toward importance of drugs in subtle ways
In the debate over weight loss medications, the FDA appears to have shifted toward the importance of drugs.
Related Articles
Mayo Clinic Laboratories and Lucence announce strategic collaboration to enhance cancer testing services – Mayo Clinic News Network
ROCHESTER, Minn., and PALO ALTO, Calif. — Mayo Clinic Laboratories, a global leader in advanced laboratory testing, and Lucence, a pioneering molecular diagnostics company, announced…
Non-canonical hepatic androgen receptor mediates glucagon sensitivity in female mice through the PGC1α/ERRα/mitochondria axis
Chen et al. uncover a function of the hepatic androgen receptor (AR) in transmitting glucagon activity, subsequently regulating glucose and lipid metabolism, and elucidate the underlying…
Apple’s Health App: 12 Tips for Storing and Tracking Medical Data on Your iPhone
The Health app on your iPhone and iPad provides an array of features to help you store, share, and track your medications, vaccine and medical…
What is RAG in AI? The low-down on Retrieval Augmented Generation
Where AI fuses precision, transparency, and cutting-edge innovation
Why Hospitals’ Revenue Growth Is Likely to Slow Down in 2025 – MedCity News
Hospitals’ operating margins dropped in November due to decreased patient demand levels and continued increases in expenses, according to a new report. One healthcare expert…
What will cloud security look like in 3 years?
Cloud security has been better than on-premises security for several years now. Increased automation and interoperability will cement its position as a best practice.
Lutetium 177 Radionuclide Therapy–Induced Proliferative Arrest in a Metastatic High-Grade Rectal Neuroendocrine Tumor
An adult man with low-volume liver metastases from grade 3 rectal neuroendocrine tumor (Ki67 index of 25%) sequentially underwent multiple systemic therapies. Gallium (88Ga)-DOTATATE scan…
Does Colchicine Lower Gout Mortality Risk? | RheumNow
Data from a large UK database finds that gout patients starting urate-lowering therapy (ULT) will benefit from added colchicine prophylaxis by having fewer cardiovascular events.
Private Equity Hospital Acquisitions and Patient Experience, Asthma Endotyping Using Nasal Epithelium, Bird Flu Update, and more
Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief, and Preeti Malani, MD, MSJ, Deputy Editor of JAMA, the Journal of the American…
Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Older Adults or Adults With Disability With Migraine
This cohort study compares the incidence of cardiovascular disease between Medicare beneficiaries with migraine who initiated anti–calcitonin gene-related peptide (CGRP) monoclonal antibodies compared with onabotulinumtoxinA.
